title: Animal models for highly pathogenic emerging viruses.
abstract: Exotic and emerging viral pathogens associated with high morbidity and mortality in humans are being identified annually with recent examples including Lujo virus in southern Africa, Severe Fever with Thrombocytopenia Syndrome virus in China and a SARS-like coronavirus in the Middle East. The sporadic nature of these infections hampers our understanding of these diseases and limits the opportunities to design appropriate medical countermeasures against them. Because of this, animal models are utilized to gain insight into the pathogenesis of disease with the overall goal of identifying potential targets for intervention and evaluating specific therapeutics and vaccines. For these reasons it is imperative that animal models of disease recapitulate the human condition as closely as possible in order to provide the best predictive data with respect to the potential efficacy in humans. In this article we review the current status of disease models for highly pathogenic and emerging viral pathogens.
authors: Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.
authors: David
authors: D
authors: Safronetz
authors: Thomas W
authors: TW
authors: Geisbert
authors: Heinz
authors: H
authors: Feldmann
mesh_terms: D000818:Animals; D021821:Communicable Diseases, Emerging / Q000821:virology*; D004195:Disease Models, Animal; D006801:Humans; D014777:Virus Diseases / Q000821:virology*
references: Antiviral Res. 2012 Sep;95(3):282-92
references: 22705798
references: Viruses. 2012 Sep;4(9):1477-508
references: 23170168
references: N Engl J Med. 2012 Nov 8;367(19):1814-20
references: 23075143
references: PLoS Negl Trop Dis. 2012;6(8):e1801
references: 22953019
references: J Virol. 2011 Aug;85(15):7658-71
references: 21593160
references: Viruses. 2012 Dec 14;4(12):3754-84
references: 23242370
references: J Leukoc Biol. 2012 Jul;92(1):205-18
references: 22517919
references: N Engl J Med. 2011 Apr 21;364(16):1523-32
references: 21410387
references: Emerg Infect Dis. 2009 Oct;15(10):1598-602
references: 19861052
references: J Infect Dis. 2013 Jan 15;207(2):306-18
references: 23045629
references: Antiviral Res. 2012 Aug;95(2):135-49
references: 22643730